Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in ...
SHANGHAI, March 19 (Reuters) - AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an ...
The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making ...
AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. Now, the Big Pharma has penned a $630 million deal for the remaining rights in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results